Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 11 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026 and Sep 2026.
- Largest single sale: $463K (3,000 shares) of Gilead Sciences on Feb 17, 2026. Filing
- Last sale before this period: Oct 15, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Gilead Sciences (GILD) | Chief Financial Officer | Nov 6, 2019 | Sep 16, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 15, 2026, Gilead Sciences: sold 3,000 shares for $436K, under a disclosed plan. 1 filing: 1
- Sep 10, 2026, Gilead Sciences: 2,797 shares vested; 1,347 shares withheld by the company for taxes. 1 filing: 1
- Aug 17, 2026, Gilead Sciences: sold 3,000 shares for $415K, under a disclosed plan. 1 filing: 1
- Jul 15, 2026, Gilead Sciences: sold 3,000 shares for $390K, under a disclosed plan. 1 filing: 1
- Jun 15, 2026, Gilead Sciences: sold 3,000 shares for $376K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.